Sequenom Shares Drop for Second Consecutive Week | GenomeWeb
Shares in Sequenom dropped 9.2 percent for the five-day trading week ended Tuesday to lead all decliners in the BCW Index. It was the second week in a row that Sequenom’s shares lost value, though there has been no recent news regarding the firm. Sequenom filed a prospectus earlier this year for the possible sale of common shares.
 
Bruker BioSciences led gainers for the week with a 5 percent jump in its stock. Bruker’s stock has been trading near its 52-week high of $11.36.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.